These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15275708)

  • 21. Review of clinical radioimmunotherapy.
    Pohlman B; Sweetenham J; Macklis RM
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):445-61. PubMed ID: 16503861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma.
    Leahy MF; Seymour JF; Hicks RJ; Turner JH
    J Clin Oncol; 2006 Sep; 24(27):4418-25. PubMed ID: 16940276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting CD20 in follicular NHL: novel anti-CD20 therapies, antibody engineering, and the use of radioimmunoconjugates.
    Leonard JP
    Hematology Am Soc Hematol Educ Program; 2005; ():335-9. PubMed ID: 16304400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunotherapy as a therapeutic option for Non-Hodgkin's lymphoma.
    Macklis RM
    Semin Radiat Oncol; 2007 Jul; 17(3):176-83. PubMed ID: 17591564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Durable responses reported with radioimmunotherapy in low-grade non-Hodgkin's lymphoma.
    Oncology (Williston Park); 2002 Mar; 16(3):304, 326. PubMed ID: 15046389
    [No Abstract]   [Full Text] [Related]  

  • 26. Radioimmunotherapy in allogeneic nonmyeloablative conditioning for B cell lymphoma: should we use it more often?
    Khouri IF
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):199-200. PubMed ID: 25528389
    [No Abstract]   [Full Text] [Related]  

  • 27. Whither Radioimmunotherapy: To Be or Not To Be?
    Green DJ; Press OW
    Cancer Res; 2017 May; 77(9):2191-2196. PubMed ID: 28428282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.
    Juweid ME
    J Nucl Med; 2002 Nov; 43(11):1507-29. PubMed ID: 12411555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New treatment may eradicate virulent lymphoma. A single course of infections kills cancers, with minimal side-effects; positive responses immediate.
    Health News; 2005 May; 11(5):6-8. PubMed ID: 15887314
    [No Abstract]   [Full Text] [Related]  

  • 30. Radioimmunotherapy of lymphoma.
    Kuzel TM; Rosen ST
    Cancer Treat Res; 1993; 68():1-12. PubMed ID: 8105845
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioimmunotherapy, a new breakthrough in the treatment of follicular non-Hodgkin's lymphoma: the European perspective.
    Chatal JF
    Cancer Biother Radiopharm; 2006 Feb; 21(1):1-4. PubMed ID: 16480325
    [No Abstract]   [Full Text] [Related]  

  • 32. B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience.
    Ulaner GA; Colletti PM; Conti PS
    Radiology; 2008 Mar; 246(3):895-902. PubMed ID: 18258810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
    Meredith RF
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S23-9. PubMed ID: 16979435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Radioimmunotherapy and Systemic Targeted Radiopharmaceutical Therapy (STaRT) programs in a radiation oncology environment.
    Macklis RM
    Am J Clin Oncol; 2006 Dec; 29(6):543-7. PubMed ID: 17148988
    [No Abstract]   [Full Text] [Related]  

  • 35. Cure of incurable lymphoma.
    DeNardo GL; Sysko VV; DeNardo SJ
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S46-56. PubMed ID: 16979440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy.
    Gokhale AS; Mayadev J; Pohlman B; Macklis RM
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):194-201. PubMed ID: 16111589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunotherapy for non-Hodgkin's lymphoma with yttrium 90 ibritumomab tiuxetan.
    Hendrix CS; de Leon C; Dillman RO
    Clin J Oncol Nurs; 2002; 6(3):144-8. PubMed ID: 11998607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of trastuzumab.
    Vogel CL; Reddy JC; Reyno LM
    Cancer Res; 2005 Mar; 65(5):2044. PubMed ID: 15753405
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiolabeled antibody therapy of B-cell lymphomas.
    Press OW
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):58-65. PubMed ID: 10561019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.